11/14/2024
3:50 PM | Inhibrx (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G/A | |
06/10/2024
4:10 PM | Inhibrx (Filer)
| Form 15-12G | |
06/03/2024
4:55 PM | HALVORSEN OLE ANDREAS (Reporting)
Inhibrx (Issuer)
Ott David C. (Reporting)
Shabet Rose Sharon (Reporting)
VIKING GLOBAL INVESTORS LP (Reporting)
Viking Global Opportunities GP LLC (Reporting)
Viking Global Opportunities Illiquid Investments Sub-Master LP (Reporting)
Viking Global Opportunities Parent GP LLC (Reporting)
Viking Global Opportunities Portfolio GP LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
4:56 PM | Inhibrx (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
| Form SC 13G/A | |
05/31/2024
3:30 PM | Inhibrx Biosciences, Inc. (Issuer)
Inhibrx (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
5:22 PM | Inhibrx (Issuer)
Lappe Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
5:23 PM | Inhibrx (Issuer)
MANHARD KIMBERLY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
5:23 PM | Inhibrx (Issuer)
Vuori Kristiina MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
5:21 PM | Deck Kelly (Reporting)
Inhibrx (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
5:21 PM | Eckelman Brendan P. (Reporting)
Inhibrx (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
5:22 PM | FORSYTH DOUGLAS (Reporting)
Inhibrx (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for INBX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Inhibrx and its competitors with MarketBeat's FREE daily newsletter. |
05/30/2024
5:22 PM | Inhibrx (Issuer)
Kayyem Jon Faiz (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
3:32 PM | Inhibrx (Filer)
| Form POSASR | |
05/30/2024
3:33 PM | Inhibrx (Filer)
| Form S-8 POS | |
05/30/2024
3:33 PM | Inhibrx (Filer)
| Form S-8 POS | |
05/30/2024
3:34 PM | Inhibrx (Filer)
| Form S-8 POS | |
05/30/2024
3:34 PM | Inhibrx (Filer)
| Form S-8 POS | |
05/30/2024
7:39 AM | Inhibrx (Subject)
Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
05/28/2024
3:55 PM | Eckelman Brendan P. (Reporting)
Inhibrx (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/24/2024
5:15 PM | Eckelman Brendan P. (Reporting)
Inhibrx (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
3:44 PM | Inhibrx Biosciences, Inc. (Issuer)
Inhibrx (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/22/2024
8:54 AM | Eckelman Brendan P. (Reporting)
Inhibrx (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/20/2024
8:48 PM | Inhibrx (Filer)
| Form DEFA14A | |
05/17/2024
4:29 PM | Inhibrx (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
3:08 PM | Inhibrx (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
3:42 PM | Inhibrx (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
3:36 PM | Deck Kelly (Reporting)
Inhibrx (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
3:22 PM | Deck Kelly (Reporting)
Inhibrx (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/22/2024
3:54 PM | Deck Kelly (Reporting)
Inhibrx (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
2:56 PM | Deck Kelly (Reporting)
Inhibrx (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/21/2024
3:36 PM | Deck Kelly (Reporting)
Inhibrx (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024
3:50 PM | Deck Kelly (Reporting)
Inhibrx (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024
3:46 PM | Deck Kelly (Reporting)
Inhibrx (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
3:48 PM | Eckelman Brendan P. (Reporting)
Inhibrx (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
3:22 PM | Deck Kelly (Reporting)
Inhibrx (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/13/2024
10:34 AM | Eckelman Brendan P. (Reporting)
Inhibrx (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/12/2024
5:04 PM | Eckelman Brendan P. (Reporting)
Inhibrx (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
3:20 PM | Deck Kelly (Reporting)
Inhibrx (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
2:28 PM | Deck Kelly (Reporting)
Inhibrx (Subject)
Inhibrx (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024
3:41 PM | Deck Kelly (Reporting)
Inhibrx (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
1:58 PM | Deck Kelly (Reporting)
Inhibrx (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
This Crypto Is Set to Explode in February (Ad) It's a groundbreaking opportunity that could be poised for extraordinary gains.
The catalyst behind this surge is a massive new blockchain development… YES, I WANT THE #1 CRYPTO NOW |
03/04/2024
5:26 PM | Deck Kelly (Reporting)
Inhibrx (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
4:26 PM | Inhibrx (Filer)
| Form PREM14A | |
02/28/2024
8:10 AM | Inhibrx (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/28/2024
8:12 AM | Inhibrx (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
